Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis

BACKGROUND: JAK (Janus kinases) inhibitors have been proposed as a promising treatment option for the coronavirus disease-2019 (COVID-19). However, the benefits of JAK inhibitors and the optimum thereof for COVID-19 have not been adequately defined. METHODS: Databases were searched from their incept...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Jianyi, Lin, Zhiwei, He, Zhenfeng, Yang, Xiaojing, Qin, Lijie, Feng, Shengchuan, Guan, Lili, Zhou, Luqian, Chen, Rongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727257/
https://www.ncbi.nlm.nih.gov/pubmed/36507538
http://dx.doi.org/10.3389/fmed.2022.973688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727257/
https://www.ncbi.nlm.nih.gov/pubmed/36507538
http://dx.doi.org/10.3389/fmed.2022.973688

Ejemplares similares